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MATHEMATICAL MODELS OF THE INFLAMMATORY RESPONSE IN THE LUNGS
By Sarah Minucci, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2017
Major Director: Angela Reynolds, Ph.D., Associate Professor, Department of Mathemat-
ics and Applied Mathematics
Inflammation in the lungs can occur for many reasons, from bacterial infections to
stretch by mechanical ventilation. In this work we compare and contrast various math-
ematical models for lung injuries in the categories of acute infection, latent versus ac-
tive infection, and particulate inhalation. We focus on systems of ordinary differential
equations (ODEs), agent-based models (ABMs), and Boolean networks. Each type of
model provides different insight into the immune response to damage in the lungs. This
knowledge includes a better understanding of the complex dynamics of immune cells,
proteins, and cytokines, recommendations for treatment with antibiotics, and a founda-
tion for more well-informed experiments and clinical trials. In each chapter, we provide
an in-depth analysis of one model and summaries of several others. In this way we gain
a better understanding of the important aspects of modeling the immune response to
lung injury and identify possible points for future research.
Chapter 1
Background
1.1 Introduction
Inflammation in the lungs can occur for many reasons, from bacterial infections to stretch
by mechanical ventilation. The immune response to these insults has been widely stud-
ied but there is still much that is unknown. Mathematical modeling allows for the
organization of biological information, a better understanding of the complex dynam-
ics involved in the immune response, and simulation and prediction of various realistic
scenarios. We will give a review of the many mathematical models that have been devel-
oped to study the immune response in the lungs. Selected models will be given a more
in-depth analysis alongside an overview of several other models and their conclusions.
1.2 Biological background
The immune response can be triggered by invading pathogens or tissue damage in or-
der to protect the body. The response of the immune cells and other mediators give rise
to inflammation. The inflammatory process begins with the recruitment of innate im-
mune cells such as neutrophils, macrophages, and other antigen-presenting cells to the
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damaged or threatened site. These cells remove the insult and send pro-inflammatory
signals to other innate and adaptive immune cells. Adaptive immune cells include T
cells and natural killer cells, which are specialized to eliminate the specific insult. Once
damaged cells have been cleared and pathogens have been removed, the subsequent
anti-inflammatory stage down-regulates the release of pro-inflammatory mediators and
suppresses activation of other immune cells. Immune cells secrete pro-resolving cy-
tokines which promotes a resolution of inflammation and return to normal functioning.
Macrophages are innate immune cells found in almost all types of tissue or recruited
to the site upon damage and/or infection. They eat pathogens and other substances
that are dangerous to healthy cells through a process called phagocytosis. Macrophages
are antigen-presenting cells, so they present these pathogens to T cells by displaying the
pathogen antigens on their surfaces and carrying them back to the lymph nodes. This
helps T cells to develop an adaptive response specific to the pathogen. Neutrophils and
dendritic cells are also important in the immune response; neutrophils contain a variety
of toxic materials to use in defense against foreign insults. Dendritic cells are another
type of antigen-presenting cell.
The innate immune system is typically activated and defends against all pathogens,
whereas the adaptive immune response is activated based on the type of damage that
occurs. This system includes B and T cells, which fight pathogens that are able to over-
come the innate immune system. These immune cells create specific mechanisms that
fight against specific pathogens. Most immune responses involve both the innate and
adaptive systems, with varying intensities of both.
There are two stages of inflammation: the pro-inflammatory phase and the anti-
inflammatory phase. These stages are classified by the cytokines that are produced
and up- or downregulate immune cells. Inflammation is first characterized by a pro-
inflammatory response, in which damaged cells and/or pathogens are destroyed. NF-
κB, a protein involved in DNA transcription, and TNF-α, a cell signaling cytokine, are
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upregulated. The second stage is anti-inflammatory, where pro-inflammatory cytokines
are downregulated and anti-inflammatory molecules, such as IL-10 and STAT3, promote
repair and a return to normal health. The proper shift from a pro-inflammatory response
to an anti-inflammatory response is extremely important, and an imbalance in either
phase can cause severe complications.
Inflammation specifically in the lungs is caused by a foreign insult or by tissue dam-
age due to stretch or strain. In this work, we will examine the different causes of lung
inflammation and how we can use mathematical modeling to understand the inflamma-
tory response in each of them.
1.3 Mathematical background
The immune system is a complex system, spanning the organ level down to the molec-
ular level. These networks, both by themselves and together, present positive and neg-
ative feedback loops, exhibit highly nonlinear behavior, and can often be quite sensitive
to small perturbations in the system. Mathematical modeling is a useful tool in both
interpreting the underlying dynamics of these systems and providing predictions and
simulations for real-life scenarios and interventions. Figure 1.1 shows the various lev-
els of interactions within the immune system that can be modeled using mathematical
techniques.
Specifically, mathematical modeling has several purposes. Cantone et al. describes
five: “(a) to inspect and integrate different but complementary types of quantitative ex-
perimental and clinical data, (b) to design experiments, (c) to elaborate, analyze and
discuss hypotheses, (d) to perform model simulation-based predictions for the course of
a disease, or (e) the feasibility of conventional, newly developed or personalized treat-
ments” [6]. According to Eberhardt et al., there are growing expectations that innova-
tions in immunology will provide “new, personalized, and targeted therapeutic options”
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Figure 1.1: The immune response can be seen as a system of systems. At the tissue
level, immune cells work to fight bacteria and protect the lung tissue. At the cell level,
cells interact with one another, sending signaling molecules back and forth. At the
intracellular level, receptors on the cell surface bind to molecules which then initiate
pathways inside the cell. Figure from Cantone et al. [6]. Reprinted with permission.
[12] for widespread diseases. Because of its quantitative nature, mathematical modeling
of immunological systems will be extremely useful in developing and simulating these
new treatments.
Various types of mathematical models are used for different biological systems, each
with their own advantages and disadvantages. We will give an overview of the most
common methods and how they are used.
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1.3.1 Boolean networks
Boolean networks are discrete models in which individual units of the model are rep-
resented as nodes and the interactions between them are represented as edges. These
units, which could be proteins, genes, or complexes, are represented by either a 0 for
“unactivated/off” or 1 for “activated/on.” Interactions such as transcription and upreg-
ulation are modeled using logic functions such as “and” and “or.”
This type of model allows for the easy incorporation of stochasticity, in which inter-
actions can be assigned a probability of occurring based on data [7]. The network can be
validated through -omics data, which consists of large-scale catalogs of molecular infor-
mation such as that from the Human Genome Project. Interactions can thus be added or
removed based on experimental results [6]. Chronological events such as translocation
to the nucleus, transcription, and subsequent translation can be modeled by assigning
timescales to groups of molecules [29]. This allows stages of reactions to occur at prede-
termined time steps based on the literature. The drawbacks to Boolean models are that
they cannot accurately represent spatial interactions or nonlinearities.
1.3.2 Agent-based models
In biological systems, reactions often occur between cells and even between molecules
that are located close to one another. Thus spatial interactions may be helpful in con-
sidering intracellular dynamics. In agent-based models (ABMs), molecules or cells are
identified as “agents” and move around a defined two- or three-dimensional space based
on rules set by the modeler and informed by the behavior of the system.
Agent-based models often replicate dynamics on more than one scale; this is called
multi-scale modeling, and it is used for many types of models in addition to ABMs.
For example, a model can measure interactions on not only at a cellular level, in which
various cells interact with one another, but also a subcellular level, where inside each cell
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is a model of interactions between molecules. This is useful in identifying how contact
between agents on a small scale can influence interactions on a larger scale and vice
versa.
One difficulty with ABMs is that they tend to be computationally intensive and thus
difficult to implement. They are very useful for simulations, but currently they cannot
be mathematically analyzed [6].
1.3.3 Differential equations
Differential equations are commonly used for modeling biological systems because of
their ability to effectively capture nonlinear behavior and demonstrate interactions be-
tween numerous variables. Each state variable represents a component of the system,
such as a cell, protein, or even a quality like overall damage [24].
Partial differential equations (PDEs) are prevalent in systems where space-dependent
dynamics are important, such as air or fluid flow. The equations govering flow are well-
studied and well-established in mathematics. Similarly to ABMs, they can also account
for spatial components, but PDEs typically account for continuous space rather than
discrete steps. However, they can be complex and therefore computationally expensive.
Ordinary differential equation (ODE) models study populations of variables over
time and are widely used; thus, there are numerous resources available for solving and
analyzing the system as well as estimating and fitting parameters. Stochasticity can also
be incorporated into each equation to account for noise in the system. The ODE method
of modeling is used most commonly to evaluate the dynamics of overall population sizes
of cells or molecules. Spatial features are generally not taken into consideration with
ODEs since ODEs assume a well-mixed environment where all elements of a system
are evenly distributed throughout the space. This is not necessarily always the case in
reality, though including multiple compartments in a model can account for different
reactions at different locations, such as the lung and lymph nodes [9, 21].
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Another disadvantage for ODEs and PDEs is the lack of experimental data available.
Experimental data guides parameter value estimation in these equations; thus, strong
parameter-fitting tools are usually needed. We will see that lack of experimental data
is a significant limitation for many of the models studied in this review. Therefore,
parameter estimation will be valuable in generating useful conclusions.
1.4 Mathematical models for the lungs
In this work, we will focus on mathematical models that examine the immune response
caused by lung injury or disease. Many of the mathematical models in this work deal
with either pneumonia [11, 23, 31, 33] or tuberculosis [9, 21, 28, 32], which are still leading
causes of death throughout the world. The models generally include the pathogen as an
input with variables that represent components of the immune response. Several also
examine antibiotics or other treatments as a variable in order to study their effectiveness
in eradication of the pathogen. The most common types of models for the immune
system are Boolean models [3, 28, 37], ABMs [5, 27, 32], and systems of ODEs [9, 10, 11,
13, 15, 19, 21, 23, 24, 25, 31, 33].
It is worth briefly noting that aside from replicating the dynamics of the immune
system itself, many models exist which focus on replicating the injuries themselves and
perhaps simulating the effect of inflammation on those injuries. Within the context of
the lungs, asthma [8, 14, 22, 17, 30] and mechanical ventilation [16, 20] seem to be two
of the most commonly modeled conditions. These are certainly related to and cause
inflammation, but for this analysis we wish to examine the dynamics of the immune
system more directly. These models generally deal more with the mechanics of the
airways, including airflow, pressure, and gas exchange.
The following chapters will address mathematical models of various types of lung
inflammation in the categories of acute infection, latent versus active infection, and par-
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ticulate inhalation. The variety of modeling methods used informs different aspects of
inflammation based on the goals of each group of authors. Furthermore, we will be
able to compare and contrast the different models and their conclusions. Through an
in-depth analysis of one model and summaries of several others in each chapter, we gain
a better understanding of the important aspects of modeling the immune response to
lung injury and identify possible points for future research.
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Chapter 2
Pathogen-Induced Inflammation:
Pneumonia & Influenza
Infections of the lungs are some of the deadliest in the world [1, 2]. Thus most of the
mathematical models focused on the immune response in the lungs are specifically for
pathogen-induced inflammation. In this chapter we will examine and compare various
mathematical models of the immune system’s response to pneumonia and influenza,
two prevalent acute infections. We will also analyze selected models in a more in-depth
manner to understand the model-building process and results.
We study pneumonia and influenza together since they both initiate acute lung re-
sponses and can be completely eradicated from the body given the proper immune
response. They also have a similar ability to mutate, pneumonia becoming resistant to
antibiotics and influenza developing new strains. This is a significant motivation for
mathematical models to be developed.
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2.1 Background & motivation
Influenza is a contagious acute respiratory disease caused by the influenza virus. Over
time, the virus goes through adaptive mutations, or even exchanges genetic material
with the avian influenza gene pool [15]. It is possible for these mutations to bypass both
the innate and adaptive immune systems and cause a pandemic, in which the population
has limited or no immunity against the newly mutated virus.
Some notable pandemics were the “Spanish flu” of 1918–19, which killed 50 million
people across the world, and the “Asian flu” (1957-58) which caused 70,000 deaths in the
US alone [15]. Interestingly enough, Hancioglu et al. noted in 2007 that “many scientists
believe that it is only a matter of time until the next pandemics occur.” Then in 2009,
H1N1 influenza A virus was named a pandemic, and caused millions of infections [19].
Pneumonia and the bacterium which most commonly causes it, Streptococcus pneumo-
niae (Sp), cause an estimated one million deaths of children age five and under per year
[1] and is especially a problem in developing countries. Co-infection of Sp with other
bacteria, most commonly tuberculosis, can also result in life-threatening conditions in-
cluding sepsis, a complication of infection, and organ failure [11].
Strains of influenza and pneumonia can become resistant to treatment. Thus new
vaccines and antibiotics need to be continually developed. Mathematical models are
extremely useful in understanding the underlying dynamics of the interactions between
these pathogens and the immune system, both innate and adaptive. In addition, they
allow for the possibility to simulate the effects of potential treatments. Therefore, these
models will aid in a more detailed and robust knowledge of the effects of various strains
of these pathogens as well as development of new and personalized treatments for the
most susceptible individuals.
Table 2.1 provides a brief summary of the specific motivations of each of the mod-
els discussed. This will provide context for subsequent sections describing the methods
used and conclusions drawn. In the rest of this chapter, we will give a more in-depth
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review of one model then compare the rest of the models together.
Anderson et al. [3] Focus on the subcellular pathways and signalling involved in
pathogenesis of the influenza virus in order to understand the
most important and powerful components of the molecular sig-
nature resulting from infection.
Domı´nguez-Hu¨ttinger et al. [11] Use four phenotypes of the host, (i) healthy recovery, (ii) sepsis,
(iii) immunological scarring, and (iv) sepsis with immunological
scarring, in order to discover the most sensitive aspects of the
immune response to pneumonia. They also include antibiotics
in their model to evaluate their effectiveness in each situation.
Hancioglu et al. [15] Explore the most influential aspects of the immune response to
influenza. They also aim to create a model that is as simple as
possible while still capturing the overall dynamics, which could
be used as the foundation for a susceptible-infected-recovered
(SIR) model.
Schirm et al. [31] Construct a model of the immune response to pneumonia in
order to predict the outcome of various schedules of antibiotic
treatments.
Mochan et al. [23], Manchanda
et al. [19]
Build simplified models that could explain the mechanisms be-
hind the varying immune responses due to specific strains of
pneumonia and influenza, respectively.
Smith et al. [33] Built their model in stages in order to understand the role of
each of their three defined stages of inflammation, and therefore
predict if the pneumonia bacteria would be cleared or sustain
growth within the host.
Table 2.1: Motivation for each model in this chapter.
2.2 Analysis of Manchanda et al.
We chose the model by Manchanda et al. [19] of the immune response to the influenza
virus to examine more closely. The aim of the model was to study and better understand
the dynamics of the immune response to several influenza strains specific to mice.
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2.2.1 Model formulation
The three-dimensional system of ODEs (Equations 2.1-2.3) represents the immune re-
sponse to influenza. The first variable P , is the pathogenicity of the virus, i.e. its ability
to cause an infection. Then we have D, the overall host immune defense, which includes
both the innate and adaptive responses. I is inflammation due to the pro-inflammatory
response. The equations are as follows:
dP
dt
= αP
(
1− P
kp
)
− βD P
P + 0.01
(2.1)
dD
dt
= γP − θD (2.2)
dI
dt
= 
(
1 + tanh
(D − δ)
ω
)
− ρI (2.3)
The authors also include a “symptom score,” adapted from Smith et al. [34]. This
symptom score is easily calculated and could shed light on the characteristics of an
infection. The symptom score S is a measure of how sick the host is, and is calculated
by:
S = P + I (2.4)
We can see that pathogenicity (P ), given by Equation 2.1 grows logistically based
on the maximum primary pathogenicity kp and is also decreased by the strength of the
immune defense (D). Immune defense growth, the first term in Equation 2.2, is propor-
tional to pathogenicity and the second term accounts for decay of the defense. Equation
2.3 shows the change in inflammation (I). It is first characterized by a hyperbolic func-
tion which models the defense’s effect on inflammation. The ratio δ/ω represents the
intensity of the inflammation. The second term in the equation demonstrates the anti-
inflammatory response.
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2.2.2 Methods and parameter estimation
The original parameter β measured the efficiency of the immune response. Using the
following transformations, β was eliminated:
β′ = 1 d−1, D′ = βD, γ′ = γβ, δ′ = δβ, ω′ = ωβ
For simplicity, the new parameters will drop the prime for the remainder of the
analysis. Thus we have only eight parameters, and can divide them into three categories:
(i) four parameters that are specific to the virus strain (α, γ, kp, ), (ii) two parameters
that are relevant to the biphasic type of infection, in which the infection has two distinct
stages (δ, ω), and (iii) two parameters that are host-specific and thus stay the same for all
strains (ρ, θ).
Descriptions of all model parameters and initial conditions are given in Table 2.2.
α Viral infection rate
κp Maximum primary pathogenicity
β′ Efficiency of immune response
γ Rate of activation of the immune system
θ Convalescense rate of immune system; immune decay
 Rate at which inflammation gets activated
δ Triggering threshold value of the defense for inflammation
ω Tolerance value of the defense for the chronic inflammation
ρ Relaxation rate of inflammation/anti-inflammatory response
P (0) Virus pathogenicity; initial value
D(0) Antiviral immune defense; initial value
I(0) Inflammation due to pro-inflammatory response; initial value
Table 2.2: Parameters and initial conditions for model. Table adapted from Manchanda
et al. [19]. Reprinted with permission.
To solve the system of equations, the authors used the R-package deSolve, and to es-
timate parameter values and their sensitivity they used the R-package FME. A Markov
Chain Monte Carlo (MCMC) simulation was used to estimate parameter uncertainty.
MCMC is a numerical algorithm that uses specific sequential steps to take random sam-
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ples of the probability distribution. This process provides information about the distri-
bution, such as uncertainty, without knowing all of the distributions analytical properties
[35].
Structural identifiability analysis helps to pinpoint which parameters can be esti-
mated simultaneously. In other words, we would like to know which parameters, when
perturbed, cannot be corrected by changing the value of another parameter. The au-
thors used the R function collin to calculate the collinearity index of every possible set
of parameters. If the collinearity index was above a certain threshold, the set was re-
garded as “poorly identifiable.” We will examine the most identifiable parameters and
their implications in the next section.
2.2.3 Results
Upon sensitivity and identifiability analyses, Manchanda et al. found three parameters
to be identifiable:
α : viral replication and infection rate
kp : maximum primary pathogenicity
γ : rate of early activation of the immune system
These parameters are also specific to the virus strain, which helps characterize the dif-
ferent virus strains studied.
We can see the fitted results in Figure 2.1. Notice that the first graph shows a unique
biphasic response, where there are two clear peaks in symptom score S. The parameters
δ and ω are only estimated for this strain, and the authors found that δ is highly sensi-
tive. In the biphasic response, D exceeds δ, creating a positive input to the hyperbolic
tanh function, thus allowing the first term in dI/dt > . This increase along with high
values of the parameters , α, γ signify the onset of inflammation. However, this is di-
rection for future research because δ, a parameter which together with ω determines if
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Figure 2.1: Experimental data and fitted model results for virus strains Jena/5258 and
Jena/5555. Figure from Manchanda et al. [19]. Reprinted with permission.
inflammation is chronic or acute, is highly sensitive for biphasic profiles while also being
non-identifiable for the other four strains.
The authors conclude that the model is able to describe the dynamics of four differ-
ent virus strains and can thus quantify the severity of each strain. Furthermore, because
of its various components, the model can explain why different strains create different
outcomes within the host. For example, the biphasic case in one of the viruses is charac-
terized by persistent inflammation, while there was low inflammation in the other three
strains studied. The authors stated that it is still unclear whether the second phase of
the biphasic case is a result of residual inflammation or caused by mutated virus that
has somehow become resistant to the immune response. This would be work for further
study.
Manchanda et al. conclude that many important factors in the immune response
to influenza can be quantified with only a few parameters, the benefits of a simplified
system. The model could also contribute to the development and optimization of virus-
specific treatments.
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2.3 Other modeling approaches
In this section we will examine several models, along with the previously analyzed
model, to see what they have in common and what they do differently. Of the seven
models in this chapter, one is a Boolean model and the other six are systems of ODEs.
Each model includes several mathematically interesting components which help to de-
scribe the pathogenesis and immune response of these infections in novel ways.
2.3.1 A Boolean model
Anderson et al. [3] used Boolean logic rules to examine the network of cellular signaling
pathways and transcription factors in dendritic cells upon response to a specific strain of
influenza. Using transcriptomics data and other available databases, the authors found
that 81 signaling pathways and 9 transcription factors were notably activated upon in-
fection with influenza.
An example of a Boolean logic rule used in the model is that which activates inter-
leukin (IL)-2, a cytokine responsible for differentiation of T-cells. Based on biological
knowledge, the presence of transcription factors CREL and NFAT is required for the
activation of IL-2 in the presence of one or more other molecules. Therefore, the rule for
IL-2 activation is as follow:
IL− 2 ON = (IRF1 OR IRF9 OR NFκB OR IL2) AND NFAT AND CREL
This model is very different from the other influenza/pneumonia models for two
main reasons: (1) it is a discrete dynamics model, and (2) it examines subcellular pro-
cesses in one type of immune cell. The other models analyze continuous dynamics
between several types of immune cells.
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2.3.2 ODE models
Though they have many similarities, each of the ODE models studies the immune re-
sponse to a pathogen using different innovative components. All of them study the
intrahost response to the pathogens that are responsible for influenza or pneumonia.
Many of them use mass-action kinetics to account for the interactions between cells and
the molecules they produce and receive as well as include the effects of antibiotics. See
Figure 2.2 for schematics of some of the models examined in this chapter.
Whereas Manchanda et al. chose not to model host cells explicitly, Domı´nguez-
Hu¨ttinger et al. chose to specify host cells by including in their model the epithelial
barrier, which is the physical barrier at which the host first interacts with the pathogen,
in this case Sp. The model, shown in Figure 2.3, quantifies the integrity of this barrier
which allows a better understanding of what happens in the immune system when it is
weakened or compromised by infection.
Another interesting aspect of this model is the two “switches” which can be described
as either on or off, R and Sv, also shown in Figure 2.3. The R switch represents the
activation of the pro-inflammatory TLR2 pathway inside epithelial cells by Sp bacteria
and Sv represents the growth of infiltrated bacteria. When Sv is off, the infection can
be cleared by the immune system without treatment, and when Sv is on, treatment is
necessary to eradicate the pathogen.
The R switch appears in the equations modeling the neutrophil population and the
strength of barrier integrity. If the R is turned on, i.e. the infiltrated bacterial load is
above a certain threshold, the TLR2 signaling pathway will be activated. Thus neu-
trophils will be more prevalent and barrier strength is decreased.
Hancioglu et al. models the effects of the viral load on epithelial cells in a different
manner. Instead of evaluating the overall integrity of the epithelial barrier, the epithelial
cell population is divided into healthy, infected, dead, or resistant to infection. The
number of dead cells is used as a measure of tissue damage. Another interesting aspect
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(a) This model focuses on the interferon and
cellular components of innate immunity as
well as adaptive immunity. Each of these
components play a specific role in fighting
the pathogen. Figure from Hancioglu et al.
[15]. Reprinted with permission.
(b) Model schematic: the pneumococcal
population P can cause epithelial cells to be
affected (EA) or unaffected (EU ). Also in-
volved are populations of macrophages (M )
and neutrophils (N ). Another interesting
component of the model is the addition of
an antibiotic to eradicate the bacteria. Fig-
ure from Schirm et al. [31]. Reprinted with
permission.
(c) In this model, overall responses are quantified, including pathogenic-
ity (P ), antiviral immune defense (D), overall inflammation due to pro-
inflammatory response (I). S is the symptom score calculated based on
the three state variables. Figure from Manchanda et al. [19]. Reprinted
with permission.
Figure 2.2: Three schematics of the mechanisms involved in the ODE models.
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Figure 2.3: Dynamics of the model by Domı´nguez-Hu¨ttinger et al.: (A) A spatial
overview of the components included in the model. (B) Interactions between the ep-
ithelial barrier, various immune cells, the blood vessel, and the pathogen. (C) Activity
of R switch. (D) Activity of Sv switch. Figure from Domı´nguez-Hu¨ttinger et al. [11].
Reprinted with permission.
of this model is the variable S, defined as antigenic distance. This is a measure of
immune memory ranging from 0 (no compatibility between the antibodies and virus
strain) and 1 (maximal compatibility). With a higher value of S, the adaptive immune
response is stronger. In an otherwise healthy individual, antigenic resistance should
increase over time, resulting in resistance to the specific strain of influenza.
Similarly, another model (Smith et al.) evaluates damage by calculating the debris D,
of dead epithelial cells and neutrophils. Through evaluating D, we can better understand
how pathogenesis of pneumonia is affected by the death of epithelial and other types of
cells.
The approach of Smith et al. is also unique in their model-building process. In order
to study the effects of each phase of the immune response, they build their model in
stages. The first stage is modeling the initial reaction of alveolar macrophages (AMs)
to the pathogen. Biologically, this makes sense because AMs are the first to respond to
the damage caused by the pneumonia bacterium. In the second stage, pro-inflammatory
cytokines produced by AMs recruit neutrophils to further contain the damage and elim-
inate the pathogen. Therefore, the second model includes neutrophils as well as divides
19
AMs into resting (not producing cytokines) and active (producing cytokines). The third
and final stage of the process adds monocyte-derived macrophages (MDMs), which re-
place neutrophils in the course of inflammation.
Although all of these models capture the immune response to influenza or pneu-
monia, each group of authors approaches their models in different ways according to
the specific parts of the response they hope to understand. Some of the most prevalent
differences are in the model-design process, how epithelial cells are represented, and the
ways in which epithelial damage is quantified. In the next section, we will see how these
distinctive models were used in generating various results.
2.4 Results and conclusions
The conclusions derived from each model in this review could be divided into two cate-
gories: (1) a further understanding of the dynamics of the innate and adaptive immune
responses, and (2) recommendations for antibiotic treatments of infection. Here we will
discuss the results obtained from the models and determine if any of the models came
to similar conclusions.
2.4.1 A deeper understanding of the immune response
Most of the models primarily strive to understand the dynamics of the immune response
to influenza and pneumonia, especially among different strains of the pathogen. Innate
versus adaptive immunity is also considered.
First of all, a sufficient adaptive immune response is enough to restore the host to
health, regardless of the magnitude of the innate immune response as well as the in-
fluenza virus itself. Hancioglu et al. were able to determine this by the influence of the
parameters bPM , bA, and gV A, which are the plasma cell production rate, antibody pro-
duction rate, and neutralization rate of the virus by antibodies, respectively. However, a
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stronger innate immune response is important in reducing the duration of infection and
amount of tissue damage [15]. Similarly, Manchanda et al. found that adaptive immunity
is one of the most impactful factors in the dynamics of influenza. This would result from
the inflammation due to pro-inflammatory cytokines, represented by the parameters α,
γ and , which are the viral replication and infection rate, the rate of early activation
of the immune system, and the rate at which inflammation is activated, respectively.
Because of the simplified nature of the model by Manchanda et al., the parameters are
much more generalized compared to those from the model by Hancioglu et al.
When examining the dynamics in different strains, Mochan et al. found that the in-
nate immune system responds differently to different strains and that the rate at which
phagocytosis occurs outside the lungs is also unique to the strain. For example, mice
with the strain BALB/c began a strong innate immune response and showed signifi-
cantly less bacteria within the first day of infection. As the bacteria reached the blood,
extrapulmonary phagocytosis, represented by a rate constant and proportional to the
pathogen population in the blood, became the most important factor in clearing bacte-
ria.
Smith et al. did not separate the immune response into innate and adaptive, but
instead showed which immune cells are most important in the immune response. They
found that alveolar macrophages alone can only clear very minor bacterial infections and
that neutrophils without monocyte-derived macrophages cannot clear more significant
inoculations. The rates of phagocytosis for macrophages and neutrophils were signifi-
cant in coming to this conclusions, since perturbing the parameters related to these rates
resulted in significant changes in dynamics. Thus using parameter sensitivity analy-
sis, they concluded that, similarly to Mochan et al., the rate of bacterial clearance by
phagocytes is one of the most important factors in a raid recovery.
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2.4.2 Recommendations for treatment
Antibacterial resistance is an issue in treating pneumonia because strains can develop
resistance to treatments, rendering antibiotics ineffective. Mathematically, the recom-
mendations for treatment are based on varying the initial bacterial load and interven-
tion time. Schirm et al. used a sum of time-dependent pulse functions in effect to model
antibiotic injections. The authors found that, beginning 24 hours after infection with Sp,
doses of the antibiotic Ampicillin every 12 hours was effective, while every 48 hours was
insufficient. Furthermore, they found a threshold of the initial number of bacteria which
determined whether or not the immune system by itself could eradicate the infection.
This could be useful in determining the least amount of antibiotics necessary to recover
from pneumonia, decreasing chances of antibiotic resistance.
Domı´nguez-Hu¨ttinger et al. also suggest optimal treatments that reduce use of an-
tibiotics. In order to eliminate the pathogen, one or more of the switches needed to be
turned off based on the different pathogenic behaviors. For example, for patients with
immunological scarring, antibiotics should reduce the bacterial threshold below a certain
threshold to turn off the R switch. Results from the model suggest that treatment within
36 hours is extremely important in preventing sepsis; this was consistent with experi-
mental observation. The authors suggest that vaccination, which activates the adaptive
immune response, could be used in the prevention of sepsis.
2.5 Assumptions and limitations
The assumptions made in the construction of each model is unique to the goals of each
group of authors, but some of the limitations are common to several of these groups, and
represent general limitations of mathematical models, especially ODE models within
mathematical biology.
Assumptions made by deterministic ODEs begin with the idea that cells are uni-
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formly distributed, and that the rate of change of any variable is determined by the
present values of these variables [15, 33]. This may not be completely realistic because of
the inherent randomness within cell systems, which is not accounted for in any of these
models.
Additionally, lack of experimental data is a constant issue for mathematical modelers,
especially when estimating parameters. In order to account for this sparsity, models are
simplified to capture the overall behavior of the immune system by leaving out some
mechanisms. For example, Hancioglu et al. left out intermediate steps in the production
of plasma cells and effector cells.
Smith et al. exclude from their model cytokines such as IL-6, which are produced
by neutrophils; instead, they assume that monocyte-derived macrophages are recruited
proportionally to the number of neutrophils present. Stating that their model is hypo-
thetical, Manchanda et al. include adaptation of the influenza virus to the host environ-
ment as a risk factor for cases of influenza with two distinct phases. They include this
because there is not enough experimental data to assume otherwise.
2.6 Further research
In light of the limitations of the models as explained in the previous paragraphs, many
of the authors stated that further work would include making the models more realistic.
This could be done by including mechanisms that were previously ignored [23], refining
parameter values [11, 15, 31, 23, 19, 33], and combining their models with other existing
models [11, 31].
Domı´nguez-Hu¨ttinger et al. propose that calibrating the model with human data
would allow direct translation into clinical settings, helping to identify personalized
treatments for patients. Models can also help to understand theoretically why some
individuals can clear out pathogens more easily than others [33].
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In addition, models that did not initially include the effects of antibiotics or other
treatments could add them in future research. Smith et al. assert that they could in-
clude a component that would allow them to find treatment strategies that eliminate
pathogens without causing further activation of the mechanisms that cause inflamma-
tion and infection.
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Chapter 3
Pathogen-Induced Inflammation:
Tuberculosis & Anthrax
In this chapter we will examine more models of pathogen-induced inflammation. We
group tuberculosis and anthrax together because the pathogens that cause these infec-
tions are not necessarily fully eradicated in the body. Instead, levels can be so low that
they are not acted upon by the immune system and are thus rendered inactive. In the
context of tuberculosis, this is called a latent infection, and no symptoms are exhibited.
For anthrax, minimal levels of anthrax spores can go undetected by immune cells. Fur-
thermore, these infections are both caused by airborne bacteria. In the same manner as
the previous chapter, we will review the model developed by Day et al. [10] and then
compare it alongside several other models.
3.1 Background & motivation
Anthrax is a serious infection caused by the bacterium Bacillus anthracis. Specifically,
inhalation anthrax occurs when anthrax spores are breathed into the lungs. Although
it is the rarest form of anthrax [36], it is of the greatest present-day concern due to its
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potential as a bioterrorism threat [10]. The immune response to anthrax is not completely
known; however, it is known that pathogenesis is significantly different from the immune
responses to other bacterial infections [10].
In contrast with the rarity of inhalation anthrax, the bacteria that causes tuberculosis,
Mycobacterium tuberculosis, is thought to infect around one-third of the world’s popula-
tion. About 5-10% of these cases actually develop symptoms [9]. With numbers of this
magnitude, tuberculosis was responsible for about 1.5 million deaths in 2015 and even
more in previous years and is thus one of the top ten causes of death in the world [2]. Al-
though many advances have been made in the prevention and alleviation of tuberculosis,
it is clear that this is an area for further investigation.
Table 3.1 shows the motivations stated in each work examined in this chapter. Gener-
ally, modelers in this chapter seek to further understand the complex dynamics of these
infections which will provide insight for development of treatments.
Day et al. [10] Understand pathogenesis of anthrax, explore early immune sys-
tem response and possible methods of antibiotics intervention.
Determine the probability of survival of individuals.
Raman et al. [28] Integrate data into a detailed computational model to under-
stand development of tuberculosis and fill in knowledge gaps.
Identify potential ways to combat disease.
Day et al. [9] Explore roles played by different types of macrophages in patho-
genesis of tuberculosis and identify when one type becomes
more dominant than the other.
Segovia-Juarez et al. [32] Investigate the complex dynamics of granuloma formation in a
tuberculosis infection.
Marino et al. [21] Build a two-compartmental model of immune response to tuber-
culosis, allowing for further and more complex investigations.
Table 3.1: Motivation for each model in this chapter.
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3.2 Analysis of Day et al.
In this section, we will examine the manner by which Day et al. [10] constructed and
analyzed their model, as well as provide a summary of their results.
3.2.1 Model formulation
The model developed by Day et al. was constructed in two phases: the first phase
replicates immune response to anthrax without any treatment, and in the second phase
the model is modified to account for the effects of two different types of antibiotics
currently used to combat the infection. It also consists of two compartments: the lung
and the thoracic and mediastinal lymph nodes (TMLN). Using a multi-compartmental
model allows for an ability to include a spatial component. Equations for each state
variable are categorized into compartments so that the model shows which compartment
holds a certain population of cells or molecules. Although this spatial concept is not as
mathematically descriptive as a PDE or ABM, it provides increased biological realism
compared to non-compartmental models. Anthrax spores are first inhaled into the lungs,
then make their way to the TMLN. Spores are benign until they interact with a host cell.
In this analysis, we will only consider the second stage of the model which includes the
effects of antibiotics, which is a system of nonlinear differential equations.
The authors adapt their model from an earlier mathematical model of anthrax infec-
tion by Kumar et al. [18]. One adjustment is that instead of assuming a similar immune
response for various types of entry of the bacteria, the new model proposes that entry via
airway initiates a different immune progression. Furthermore, Day et al. create a sim-
plified model due to gaps in knowledge throughout the literature concerning anthrax.
Similar to Manchanda et al., the authors also note the benefit of a simplified model:
fewer variables and parameters to estimate. A list of parameters and their descriptions
are shown in Table 3.2.
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Be max Be carrying capacity
ct1, ct2, ct3 Controls effectiveness of anthrax toxins to inhibit neutrophil processes
ctb Saturation of production of anthrax toxin by bacteria
C Ciprofloxacin treatment amount
D Doxycycline treatment amount
k1 Rate of apoptosis of immune cells after interaction with Be
k2 Rate at which resident lung cells phagocytose anthrax spores
k3 Rate at which spore-containing host cells migrate to MLN and release bacteria
k4 Rate of production of anthrax toxins by bacteria
k5 Growth rate of Be
k6 Rate at which MLN immune cells kill Be
k8 Rate of phagocytosis and killing of Be by N
k9 Rate at which resting neutrophils are activated by Be
k10 Rate at which resting neutrophils are activated by other neutrophils
N0 Source of resting neutrophils
nb Number of bacteria inside a host cell after migration to MLN
ns Number of spores phagocytosed by resident lung host cells
sA Source of resident lung host cells
sE Source of resident immune cells in MLN
µA Natural death rate of of resident lung host cells
µE Natural death rate of immune cells in MLN
µN Natural death rate of primed neutrophils
µTA Decay of anthrax toxins
Table 3.2: Parameters for model of anthrax in the lungs. Table adapted from Day et al.
[10]. Reprinted with permission.
The equations for the lung compartment are:
dA
dt
= −k2SA+ sA − µAA (3.1)
dS
dt
= −k2SA (3.2)
dH
dt
=
k2SA
nS
− k3H, (3.3)
where variables are alveolar phagocytes (A), accounting for both alveolar macrophages
and dendritic cells, spores (S), and host cells (H), which engulf and essentially “host”
the bacteria.
Because the phagocytosis of spores (S) by alveolar phagocytes (A) happens so quickly,
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the authors chose A to be at a quasi-steady state, where there is no delay in the internal-
ization of spores. Thus by setting dA/dt to be equal to 0, the equation becomes:
A =
sA
k2S + µA
The initial condition represents the number of spores that are first inhaled into the lungs.
The authors test various initial spore loads to determine their effects on survival. In the
model, spores are inhaled into the lung where they interact with alveolar phagocytes.
The phagocytes ingest the spores, thus becoming host cells. These host cells then carry
the anthrax to the TMLN, where they cause further damage to their surrounding envi-
ronment. Figure 3.1 shows a visual representation of what is occurring first in the lungs,
then further downstream in the TMLN.
Variables represented in the TMLN are extracellular bacteria, i.e. bacteria that has
germinated and been released from the host (Be), neutrophils (N ), and toxins produced
by the bacteria (TA). Furthermore, Bc and Bd represent bacteria affected by antibiotics
Ciprofloxacin and Doxycycline, respectively.
As they make their way to the TMLN, spores inside host cells germinate to become
bacteria. The amount of time through which spores enter the airway, are ingested by
phagocytes, and germinate is denoted the PMG (phagocytosis, migration, germination)
period by the authors. This concept is explored later in our analysis. Once the bacteria
germinate, they multiply and produce toxins which destroy the host cell. The bacteria
thus become extracellular (variable Be) and produce anthrax toxins (variable TA).
These toxins interact with neutrophils (variable N ) and prevent them from killing
bacteria. Anthrax toxins also prevent the ability of neutrophils to mediate bacterial
damage through mobility and priming. These interactions cause the inflammation in the
mediastinum which characterizes fatal anthrax cases. Inhibition of immune cell efficacy
by toxins is shown in the equations through the fraction 1
1+
TA
ct
multiplied by several
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Figure 3.1: Schematic for the two-compartment model of anthrax infection. Spores inter-
act with alveolar phagocytes, which translocate to the TMLN. There, spores germinate
and are able to destroy cells and release toxins. Figure from Day et al. [10]. Reprinted
with permission.
terms in equations for extracellular bacteria (Be), bacteria affected by Ciprofloxacin and
Doxycycline (Bc and Bd, respectively), and neutrophils (N ).
As mentioned above, Day et al. include the effects of two antibiotics in their model.
Each antibiotic interacts with anthrax bacteria in a different way: Ciprofloxacin causes
bacterial cells to die upon division, while Doxycycline does not kill bacteria, but instead
prevents bacterial cells from growing. This allows the immune system to clear out the
pathogen naturally without the threat of increasing amounts. Thus the term
−k5Bc
(
1− Be +Bc +Bd
Bemax
)
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in the Bc equation, which represents death of bacteria due to the antibiotic, is unique to
Cyprofloxacin effects. This does not occur for bacteria affected by Doxycycline, Bd, and
thus dBd/dt does not include a similar term. The Centers for Disease Control and Pre-
vention (CDC) recommends that individuals are treated with one or the other. Therefore,
simulations are run with the effects of either Ciprofloxacin or Doxycycline.
The authors modeled the effects of these antibiotics according to the biological mech-
anisms they use. In Equation 3.4, antibiotics are included as constants C and D. Notice
that Equation 3.5 shows three methods of eradicating the bacteria with the effects of
Ciprofloxacin included: the second term represents cells killed upon division, the third
term represents cells killed by the early immune response, and the fourth term repre-
sents cells ingested by neutrophils. Equation 3.6, bacteria affected by Doxycycline, only
contains the latter two terms because the antibiotic itself does not kill the bacteria.
Equations for the TMLN compartment are as follows:
dBe
dt
= k3nBH + k5Be
(
1− Be +Bc +Bd
Be max
)
− k6EBe
− k8NBe
1 + TA
ct1
−BeC −BeD + kdBd (3.4)
dBc
dt
= BeC − k5Bc
(
1− Be +Bc +Bd
Be max
)
− k6EBc − k8NBc
1 + TA
ct1
(3.5)
dBd
dt
= BeD − k6EBd − k8NBd
1 + TA
ct1
− kdBd (3.6)
dN
dt
=
k9BeEN0
1 + TA
ct2
+
k10NN0
1 + TA
ct3
− µNN (3.7)
dTA
dt
= k4
Be
ctb +Be
− µTAT (3.8)
In the next section we will examine how the authors use this model to obtain inter-
esting results about the immune response to anthrax infection.
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3.2.2 Results
Day et al. perform several types of analyses in order to understand on a cellular level
what promotes survival in individuals with inhalation anthrax. First, a sensitivity anal-
ysis was conducted on 15 of the 23 parameters as well as initial conditions to check
which parameters most affected bacterial load and neutrophil population, which are
both indicators of the “healthiness” of the individual.
The sensitivity analysis revealed that the most important parameters were those re-
lated to the killing of extracellular bacteria Be:
k6: rate at which resident immune cells in MLN kill Be,
E(0): initial condition for number of immune cells in MLN, and
k10: rate at which resting neutrophils are activated by already activated neutrophils.
Furthermore, given various initial amounts of anthrax spores, the model was able
to show how long antibiotic treatments should last. Figure 3.2 shows the results. The
authors determined that a duration of 100 days of treatment with Ciprofloxacin and 70
days with Doxycycline is unrealistic and therefore represents the death of the individual.
We can see that with the highest amount of spores, S(0) = 2 × 107, there is no chance
of survival given the current antibiotics. is However, for the other initial levels of spores
and intervention times, survival with antibiotic treatment is possible. Furthermore, the
authors were also able to conclude that although the two antibiotics target the bacteria
through different mechanisms, their effectiveness is about the same.
Another novel aspect of the model was the PMG period. Antibiotics currently used
to treat inhalation anthrax assume that germination of the bacteria can be delayed or
occur over a longer period of time. By varying the parameter k3 the authors examined
the effects of shortening or lengthening the PMG period. The model revealed that a
longer PMG period causes survival of more anthrax spores initially. A shorter PMG
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(a) Treatment with Ciprofloxacin. (b) Treatment with Doxycycline.
Figure 3.2: Number of days that the individual should be treated with antibiotics for
survival for different initial numbers of spores inhaled. The authors suggest that treat-
ments of 100 days or more is unrealistic and thus represents death. Figure from Day et
al. [10]. Reprinted with permission.
period induces faster initial growth of bacteria, which causes antibiotics to activate more
quickly, thus requiring less antibiotics in the long run and reducing the duration of
the infection. Understanding the effects of PMG period could be extremely useful in
determining the effectiveness of antibiotics and informing duration of treatment as well
as quantity.
Overall, the model was able to predict the survival of the host based on initial spore
load as well as examine which mechanisms of the immune system were most important
in eradicating bacteria. It could be further developed to include more information about
anthrax as it becomes available as well as inform decisions about antibiotic treatment.
3.3 Other modeling approaches
Along with the model by Day et al., we will examine four other models of infection with
tuberculosis. Of the five models, three are systems of ODEs, one is an ABM, and one
is a Boolean model. Each have varying levels of complexity and different components.
In this section, we briefly examine and compare the model-building process and their
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components. Figures 3.3 and 3.4 shows the mechanisms involved in each mathematical
model. Notice the varying levels of complexity and different focuses by which aspects
of infection each group decided to investigate.
(a) Three-compartment model study-
ing the interactions between clas-
sically and alternatively activated
macrophages. Figure from Day et al.
[9]. Reprinted with permission.
(b) Diagram for state of macrophages
in ABM. Depending on which other
cells they interact with, they can fall
into several different categories, such
as active, resting, or dead. Figure from
Segovia-Juarez et al. [32]. Reprinted
with permission.
(c) Two-compartment model focusing
on role of macrophages. Undifferenti-
ated macrophages eventually take on a
phenotype which can result in various
outcomes. Figure from Marino et al.
[21]. Reprinted with permission.
Figure 3.3: Schematics for three models analyzed in this section.
When comparing the schematics of each model, one of the first things we notice is the
level of detail, especially the difference in detail between the Boolean model by Raman
et al., shown in Figure 3.4 and the other models, shown in Figure 3.3. We also saw this
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Figure 3.4: Schematic for model by Raman et al.; the Boolean model includes molecules
from the host and pathogen, cells, cellular processes, and vaccination effects. Figure
from Raman et al. [28]. Reprinted with permission.
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in Chapter 2 between the Boolean model and the six other ODE models. Boolean models
usually include more detail because of their computational nature, the large amount of
transcriptomics data available, as well as the benefit of not needing to calculate parame-
ters.
One of the key features of several of the models is multiple compartments. As pre-
viously stated, Day et al. included both a lung compartment and a compartment for
lymph nodes in their model of anthrax infection. The model by Day et al. for tubercu-
losis includes both of these components as well as the interstitum, which is the tissue
between alveoli and the blood stream. We can also see that in the tuberculosis model,
most of the dynamics occur within the lung/airspace whereas in the anthrax model the
majority of interactions were in the lymph node. The model by Marino et al. is also a
two-compartmental model, accounting for the lung and lymph node.
Three out of the five models also focus heavily on the role of macrophages and
their type of activation. Day et al. (2009) and Marino et al. examine the differences
between roles of alternatively activated macrophages (AAM) and classically activated
macrophages (CAM). Segovia-Juarez et al. examined granuloma, which are collections of
macrophages responding to a particular pathogen. Macrophages can be found in several
different states, including active, infected, and dead. It is clear that macrophages play an
important role in the immune response to tuberculosis and that a greater understanding
of its functions could be very useful in determining the best treatments.
3.4 Results and conclusions
Similarly to anthrax, response time by the immune system is important in the survival of
the host when infected with M. tb. Furthermore, activation of macrophages was found
to be a sensitive aspect of the mechanisms involved. These are two results that seemed
to be prevalent through each model. The models also seek to understand the differences
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between latent and active infections.
Including a few parameters in their model to account for events that occur later in
time, Raman et al. observed that the adaptive immune response is critical in tuberculo-
sis and that based on their model, an innate immune response may not be enough. The
parameter δAI represented the delay in the adaptive immune response, with δAI = 0 rep-
resenting a vaccinated individual. They also noted that the growth rate of bacteria and
subsequent time taken to enter into an active state could be important in determining
disease outcome. Bacterial load was also an important point of discussion for Day et
al. (2009). In agreement with Raman et al., the authors state that based on model sim-
ulations, reducing bacterial populations and the peak bacterial load could be effective
treatment strategies rather than focusing on mediators in downstream signaling. In fact,
an increase in the parameter k16, which controls the ability of infected alternatively ac-
tivated macrophages to inhibit bacterial growth, decreases bacterial loads but increases
the switching time. So an ideal treatment would decrease bacterial loads without influ-
encing later signaling as a result.
Spatial knowledge of the system from an ABM is extremely useful. Through devel-
oping a better understanding of granuloma formation, Segovia-Juarez et al. found that
bacterial growth was an important factor, as well as recruitment of T cells to the sites
of infected macrophages. They conclude that although a certain number of T cells is
not sufficient for immune response efficacy, the locations of T cells is important. Ideally,
there is a large enough quantity of macrophages to block the spread of bacteria, but
not so large that T cells cannot reach bacteria and infected cells. Based on the model, a
speedy T cell response results in complete eradication of bacteria.
Marino et al. examine the immune response at a molecular level, in which their
model suggests that TNF-α, a pro-inflammatory protein, is more useful in mediating
macrophage phenotype than bacterial load. This was determined through virtual deple-
tion, where an element such as TNF-α can be gradually depleted in the model due to a
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simulated treatment. As stated in the previous section, polarization of undifferentiated
macrophages towards either classically or alternatively activated is crucial in the devel-
opment of the infection, and the model shows through sensitivity analysis that this is
largely TNF-α-dependent.
Day et al. (2009) proposed a concept for alternatively and classically activated macro-
phages which they called switching time. This is the time point at which AAM outnum-
bers CAM, which, as stated previously, is determined by the parameter k16, the ability
of infected alternatively activated macrophages to inhibit bacterial growth. Marino et al.
adapt this approach for their model as well, where AAM immediately become infected
when they engulf a bacterium and CAM kills the bacterium. Figure 3.5 shows baseline
results from the model by Day et al. (2009). First, AAM outnumber CAM but after 50
days CAM becomes the predominant type of macrophage. In their models, both groups
analyzed the effects of decreasing the switching time so that fewer AAM will be infected
and more CAM will kill bacteria in a given amount of time.
Figure 3.5: Baseline simulation from Day et al. shows the populations of AAM and CAM
over 100 days. The switching time, where AAM outnumbers CAM, is shown at 50 days
when the two curves intersect. Figure from Day et al. [9]. Reprinted with permission.
Recommendations for treatment as informed by the models would include a faster re-
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sponse by the immune system, which could be achieved through vaccination. Response
from classically activated macrophages and T cells are especially significant, which could
reduce bacterial loads earlier on in the infection. This was confirmed using different
types of models, highlighting the importance of diversity in modeling techniques.
3.5 Assumptions and limitations
Similarly to the models for influenza and pneumonia, those in this chapter are limited
by a lack of sufficient experimental data and knowledge about the exact mechanisms
employed by the immune system.
Some other assumptions were made for the sake of simplifying the mathematical
model and quantifying mechanisms that can be difficult to measure. For example, Day
et al. modeled the thoracic and mediastinal lymph nodes as one compartment, although
biologically they are two separate entities. Furthermore, since it is not completely known
which phagocytes in the lungs actually ingest anthrax spores, the authors added the
simplification of generalizing all types of alveolar phagocytes into the A and H variables.
Segovia-Juarez et al. also bring up the limitation of a lack of stochasticity in their
model. This and the Boolean network are the only models in this chapter which in-
cluded stochasticity. Although they include some stochastic rules, such as some related
to recruitment of T cells and macrophages and activation of macrophages, not all aspects
of the model has stochasticity. They note that the velocity of T cells varies in reality, al-
though it is kept as a constant in their ABM. Furthermore, the probabilistic parameters
used in the stochastic rules may not be completely realistic.
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3.6 Further research
In addition to adding greater detail to the models as more information becomes avail-
able, the authors of each model brought up intriguing areas for further investigation.
Raman et al. propose the possibility of creating “virtual patients,” in which host-specific
variations in the model could be incorporated in order to determine more individualized
interactions and treatments. Segovia-Juarez et al. plan to incorporate more information
about the cytokine IFN-γ which is involved in macrophage activation; this could pro-
vide new knowledge about the role of IFN-γ and T cell interactions with macrophages.
Additionally, all of these models could inform the design of more effective and focused
real-life experiments.
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Chapter 4
Agent-Based Models of Particulate
Inhalation
In this chapter we will examine two ABMs for other types of insults. We will compare
the components of each model and the methods used to draw conclusions. We will also
present the results of each model and possibilities for future work.
4.1 Background & motivation
Few models have studied the effects of inflammation due to other types of insults besides
infectious diseases. As stated in Chapter 1, mathematical models have been developed
for asthma and mechanical ventilation, but they do not explicitly model the immune sys-
tem. In this chapter, we examine how two agent-based models can capture the dynamics
of the immune response to asthma and to general particle inhalation.
Asthma is a chronic inflammatory disease with severity varying from patient to pa-
tient and can be difficult to manage [27]. Through isolated asthma attacks, constriction
of the bronchial tubes occurs and remodeling of the airways can occur through repeated
attacks over time [8]. Airway remodeling is also an issue for the inhalation of dan-
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gerous particles due to smoking as well as air pollutants and occupational exposure.
Depending on the size of the particle and the duration and frequency of the exposure,
various immune responses can be elicited [5]. Smoking can lead to Chronic Obstructive
Pulmonary Disease (COPD), which is a largely irreversible condition characterized by
chronic inflammation [4].
For these conditions, the dynamics of the immune response are still incompletely
understood. Pothen et al. [27] and Brown et al. [5] developed models of the immune
response to particulate inhalation under different circumstances, in order to further un-
derstand the medical conditions.
4.2 Analysis of Pothen et al.: asthma
4.2.1 Model formulation
In the ABM by Pothen et al., the hypothesis of the “inflammatory twitch” is tested in the
context of asthma. This inflammatory twitch is a term coined by the same authors in a
previous paper [26], in which stimulation of the immune system by an antigen causes
inflammation as well as resolution back to normal. They further hypothesize that an
asthma attack is characterized by a partial inflammatory twitch; the immune system
activates inflammation but is unable to resolve it. The question that the authors hope to
answer is, what mechanisms are responsible for the interrupted inflammatory twitch?
For this model, agents are immune cells including mast cells, antigen-presenting
cells, helper T cells, and pro- and anti-inflammatory cells. Mechanisms for the immune
response to asthma included in the model are shown in Figure 4.1. The response is
triggered by breathing in foreign particles.
The basic rules for the model are:
1. Particles are “released” into the system, which mimics an asthmatic response to
particle inhalation.
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Figure 4.1: Mechanisms for inflammation due to asthma. Mast cells and APCs are
activated upon encounter with antigen. Figure from Pothen et al. [27]. Reprinted with
permission.
2. Antigen-presenting cells (APCs) move towards particles and release signals while
digesting particles.
3. An APC becomes inactive for a user-set amount of time if it encounters a user-set
number of particles.
4. Helper T cells move towards APC signals and release pro-inflammatory cytokines
for 10 time steps (where 15 time steps equals 1 day).
5. T-regulatory cells move towards pro-inflammatory cytokines; while they move to-
wards pro-inflammatory cytokines, they release anti-inflammatory cytokines.
Similarly to other models we have examined, this ABM has developed a method to
quantify health. The rules built into the ABM for the health value are:
1. The scale varies from 0 to 100, where 100 is perfect tissue health with no damage.
2. Each patch has a health value.
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3. When a pro-inflammatory cell is on a patch, if the cell moves toward a chemical
signal, subtract 5 from the health of the patch. If it does not, subtract 2.
4. If an anti-inflammatory cell lands on a patch with less than perfect tissue health,
add 1 to the patch’s health.
Now that we have established the components of this model, we will examine those
of the model from Brown et al., then compare their results.
4.3 Analysis of Brown et al.: smoking
4.3.1 Model formulation
This model was developed in order to understand the development of Chronic Obstruc-
tive Pulmonary Disease (COPD), which is often seen in smokers. In COPD, macrophages
respond more intensely to particle inhalation, resulting in a positive feedback loop of
pro-inflammatory response. The mechanisms that make up the model are shown in the
schematic in Figure 4.2.
Figure 4.2: Upon inhalation to particles of different sizes and concentrations,
macrophages react in various ways. Figure from Brown et al. [5]. Reprinted with per-
mission.
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Similarly to the ABM by Pothen et al., this one includes a simplified system with
abstracted populations of cells. The authors noted that in reality, multiple cells could fall
under the category of one variable. In other words, macrophages in the model represent
many inflammatory cells including neutrophils and lymphocytes. Furthermore, TNF-α
represents all pro-inflammatory cytokines, and anti-inflammatory cytokines are repre-
sented by TGF-β1. With this in mind, the two models have very similar components and
interactions. One distinction for the Brown et al. model is the inclusion of collagen, a
protein in connective tissue, and fibrobasts, which are cells that maintain the structural
integrity of connective tissue.
Additionally, the model was run for 10,000 time steps following exposure. The au-
thors do not specify how these time steps correspond to real time, but conclude that
10,000 iterations of the model is sufficient to determine if the inflammation could be
resolved or not.
Rules for the model include:
1. A user-set number of particles are “released” to begin the simulation.
2. Macrophages on the same patch as a particle become activated for 50 iterations.
3. Macrophages are also activated on patches with more than 5 units of collagen.
4. Activated macrophages release pro-inflammatory cytokines and for the last 5 iter-
ations of activation, they release anti-inflammatory cytokines.
5. Fibroblasts move towards and heal damaged tissue by depositing collagens and
increasing the “Tissue Life” value.
6. Particles are degraded by macrophages when the particle’s degradation value is
equal to 10; degradation = (number of macrophages on the same patch as the
particle)(number of iterations macrophages have been on the patch)
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This model quantifies tissue damage similarly to the one by Pothen et al.. Tissue Life
is measured on a percentage scale, where 100% represents a perfectly healthy patch of
tissue. The presence of pro-inflammatory cytokines (TNF-α) on a patch decreases Tissue
Life. This was the first variable investigated by the authors when determining the results
of the simulation and the effects of various particle sizes and amounts.
4.4 Results and conclusions
With an ABM, the modeler can change the rules in each simulation in order to recreate
various scenarios, including inflammation as a result of asthma or smoking.
In the analysis by Pothen et al., the baseline simulation was a normal inflammatory
twitch where tissue health returns to normal. Figure 4.3 shows the control simulation
along with simulations for various modifications of the model. The most damage done
to lung tissue in the model was by increasing the lifespan of pro-inflammatory cells such
as neutrophils. The authors concluded, therefore, that a possible therapy option could be
increasing apoptosis in neutrophils to decrease the magnitude of the pro-inflammatory
response.
For the model by Brown et al., instead of changing the mechanisms of the immune
response, different sizes and quantities of particles were chosen to activate the system
for each simulation. The authors found that based on the degree and duration of parti-
cle exposure, the model elicited three distinct states: (1) self-resolving inflammation, (2)
localized tissue damage and fibrosis, and (3) persistent tissue damage and fibrosis. The
number of particles as well as the frequency and duration of exposure were all factors
that contributed to localized and persistent tissue damage and fibrosis; thus, the immune
response resulting in these states are likely a combination of all three influences. How-
ever, simulations suggest that the situation causing the most damage would be through
increased particulate exposure at higher frequencies, even with short duration.
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Figure 4.3: The authors ran several simulations with varying modifications. Each curve
represents the average of 100 simulations. The control is a normal inflammatory twitch.
Other simulations include: increased pro-inflammatory cell (PIC) duration, mast cell
knockout, Th cell knockout, and reduced survival of pro-inflammatory cytokines. Figure
from Pothen et al. [27]. Reprinted with permission.
Furthermore, the authors also noted that both localized and persistent tissue damage
is characterized by high overall levels of pro-inflammatory cytokines as well as a high
number of pro-inflammatory cytokines per macrophage. This is consistent with the
findings of Pothen et al. They conclude that the localized and persistent states are likely
a combination of these factors with others in the system.
As opposed to a system of ordinary differential equations where it is assumed that
all individuals of the population are well-mixed in the space studied, an ABM reveals
the spatial components and how locations of cells affect the dynamics of the system.
Figures 4.4 and 4.5 show simulations of each model and how considering space can
provide useful insights. Brown et al. especially emphasizes the significance of using
a spatiotemporal model, supporting the need to include spatial components in future
models.
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Figure 4.4: Simulations from Brown et al. in a section of lung tissue representing each
state: (A) self-resolving inflammation, (B) localized tissue damage and fibrosis, and (C)
persistent tissue damage and fibrosis. Darker areas represent damage. Figure from
Brown et al. [5]. Reprinted with permission.
Figure 4.5: Simulation from Pothen et al. for a normal immune response. The red area
is the capillary, the blue patches are the endothelial barrier, and the gray is the alveolar
tissue. Darker areas represent damage. Notice that darker areas (i.e. damaged patches)
are clustered together in the bottom middle and top left of the alveolar tissue. Figure
from Pothen et al. [27]. Reprinted with permission.
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4.5 Further research
The goal of constructing both of these models was to further understand the complex
dynamics of the immune response to particle inhalation under different circumstances
and potentially provide insight into treatments for asthma and COPD. However, because
these insults have not been widely studied in mathematical models, the models by Brown
et al. and Pothen et al. are first steps into their computational investigation. Both groups
of authors acknowledge the simplification of grouping cells and molecules together as
APCs, macrophages, and pro- and anti-inflammatory cytokines. Brown et al. stated that
improvements upon the model could be made by distinguishing neutrophils, T cells,
eosinophils, and epithelial cells. This would allow for a more detailed understanding of
the mechanisms that cause inflammation. Pothen et al. also note that they have not taken
full advantage of the spatial aspect of the model, and that it could be further studied in
the future.
The two agent-based models studied in this chapter have many similarities and ob-
tain similar results. However, each model examines results differently; Brown et al.
chose to focus on three states of increasing damage intensity due to various types of
exposure to particulate inhalation. On the other hand, Pothen et al. chose to focus on
the isolated mechanisms that could affect the inflammatory twitch, providing possible
explanations for asthma-induced inflammation. Both concluded that spatial dynamics
are extremely useful in identifying areas of tissue damage, and that it is likely that the
presence of pro-inflammatory cytokines is an influential aspect of the positive feedback
loop of inflammation.
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Chapter 5
Conclusion
In summary, we gave an overview of the biological processes involved in the immune
response to lung insults and outline the types of mathematics used to model these sys-
tems, each with their own advantages and disadvantages. The greatest motivation for
constructing models of the immune response in the lung is to further understand the
complex dynamics of immune cells and proteins.
For influenza and pneumonia, unique components of the models included switches
that determined important bifurcations in inflammation [11] and building a model in
stages [33]. In order to better understand the injury caused to epithelial cells, quantify-
ing damage is important and was achieved using a different method in each model. Two
conclusions especially highlighted by several models for the immune response to pneu-
monia and influenza are (1) that the rate of bacterial clearance through phagocytosis is
important, and (2) that the effects of antibiotics can be modeled, providing insight into
the issue of antibiotic resistance and overuse.
Understanding the underlying dynamics of the immune response was the most im-
portant motivation for the models of tuberculosis and anthrax, since there are many
gaps in the knowledge about these infections. Two-compartment models were charac-
teristic in this chapter, whereas they were less of a focus in the models of influenza and
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pneumonia. The mechanisms that had the greatest influence on the survival of the host
were (1) the response time of the immune system, (2) macrophage activation (CAM vs.
AAM), and (3) the bacterial load.
Not many mathematical models focus on the immune response to non-bacterial in-
sults. The two ABMs studied in Chapter 4 examined particulate inhalation under differ-
ent circumstances. The methods used to measure tissue health were similar, and both
models concluded that the most influential factor on tissue health was the effects of pro-
inflammatory cytokines. The spatial component of these ABMs, which the two ODE
models studied in Chapters 2 and 3 do not include, shows results that could not be
observed without accounting for space. This further confirms the necessity of multiple
mathematical methods in order to gain more comprehensive knowledge of the immune
response to various pathogens.
It is clear that the immune response is unique to each insult and that mathematical
models should be individualized for each type of pathogen. Due to the lack of ex-
perimental data available and limited biological knowledge, further experimentation is
important for developing these models. Fortunately, the models themselves provide use-
ful recommendations for experiments. Furthermore, the benefits of simplified models
are highlighted in this review and models such as the three-dimensional one by Man-
chanda et al. can in fact capture the dynamics of the immune response very well when
fit to the available experimental data. Additionally, the quantification of damage using
different techniques as well as the focus on distinct states of inflammation separated by
manifolds or switches provide insight into the complex biological mechanisms of the
immune response, further revealing the usefulness of mathematical modeling of lung
inflammation.
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Appendix A
Permissions
Figure 1.1 From Cantone et al. [6], Creative Commons license (Frontiers).
Figure 2.1 From Manchanda et al. [19], permission to reproduce figure granted by Elsevier.
Figure 2.2a From Hancioglu et al. [15], permission to reproduce figure granted by Elsevier.
Figure 2.2b From Schirm et al. [31], Creative Commons license (PLOS).
Figure 2.2c From Manchanda et al. [19], permission to reproduce figure granted by Elsevier.
Figure 2.3 From Do´minguez-Hu¨ttinger et al. [11], Creative Commons license (Frontiers).
Figure 3.1 From Day et al. [10], permission to reproduce figure granted by Elsevier.
Figure 3.2a From Day et al. [10], permission to reproduce figure granted by Elsevier.
Figure 3.2b From Day et al. [10], permission to reproduce figure granted by Elsevier.
Figure 3.3a From Day et al. [9], permission to reproduce figure granted by PNAS.
Figure 3.3b From Segovia-Juarez et al. [32], permission to reproduce figure granted by Elsevier.
Figure 3.3c From Marino et al. [21], permission to reproduce figure granted by Elsevier.
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Figure 3.4 From Raman et al. [28], permission to reproduce figure granted by the Royal
Society of Chemistry.
Figure 3.5 From Day et al. [9], permission to reproduce figure granted by PNAS.
Figure 4.1 From Pothen et al. [27], permission to reproduce figure granted by Elsevier.
Figure 4.2 From Brown et al. [5], permission to reproduce figure granted by Elsevier.
Figure 4.3 From Pothen et al. [27], permission to reproduce figure granted by Elsevier.
Figure 4.4 From Brown et al. [5], permission to reproduce figure granted by Elsevier.
Figure 4.5 From Pothen et al. [27], permission to reproduce figure granted by Elsevier.
Table 2.2 Adapted from Manchanda et al. [19], permission to reuse granted by Elsevier.
Table 3.2 Adapted from Day et al. [9], permission to reuse granted by Elsevier.
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